newsfilter
← Latest News
GlobeNewswire·

Lumexa Imaging Announces Third Quarter 2026 Results

LMRI
  • Lumexa Imaging reported third quarter 2026 consolidated revenues of $272.0 million, representing a 5.0% increase year-over-year.
  • Advanced outpatient volumes grew 7.9% consolidated, accounting for 31.8% of the total procedure mix.
  • The company recorded a net income of $7.2 million for the quarter, reversing a net loss of $3.5 million in the same period last year.
  • Adjusted EBITDA reached $62.6 million, with an Adjusted EBITDA margin of 23.0%.
  • GAAP earnings per share were $0.07, while Adjusted earnings per share were $0.26.
  • Lumexa Imaging reiterated its full-year 2026 consolidated revenue guidance range of $1.045 billion to $1.097 billion.
  • The company narrowed its full-year Adjusted EBITDA guidance to $236 million to $240 million.
  • Adjusted EPS guidance for 2026 was raised to $0.86 to $0.90 per share.
  • The company is actively opening three new de novo centers, on pace to achieve 8 to 10 new openings for the full year.
  • Total assets as of September 30, 2026, were $1.83 billion, with cash and cash equivalents increasing to $90.0 million.
  • System-wide advanced outpatient volume growth reached 8.1%, with same-center advanced volume growing 6.8%.
  • General and administrative expenses increased to $30.0 million from $17.1 million in the prior year quarter.
  • Interest expense decreased to $15.7 million from $30.6 million in the previous year quarter.
  • The company operates 190 outpatient imaging centers as of September 30, 2026, including 87 joint ventures and 103 consolidated locations.
  • A conference call to discuss the results is scheduled for November 10, 2026, at 5:00 p.m. ET.
Company
Lumexa Imaging, Inc.
Keywords
Nasdaq:LMRI, Lumexa Imaging, Inc.